Clinical Trials
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 1–12 of 376 articles
Quick answer
NovaPharmaNews Clinical Trials hub for FDA covers 376 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
FDA Grants Orphan Drug Nod to IKT-001 for PAH
FDA Grants Fabhalta Traditional Nod, -48% eGFR Slope
FDA Fast Tracks Lundbeck Lu AH69593 for Narcolepsy
Monopar Starts Rolling NDA for ALXN1840 Wilson
FDA Accepts BridgeBio Encaleret NDA for ADH1
FDA Accepts Daraxonrasib NDA for Pancreatic Cancer
FDA Accepts Dyne BLA for z-Rostudirsen in DMD
Summit Therapeutics Refocuses on Oncology Drug
Lexitas Ocusun dose first patient in cataract pilot
FDA approves Merck oral PCSK9 drug
AACR/ASCO Methods in Clinical 2026 Preview
Enlicitide Wins FDA Nod as First Oral PCSK9 Inhibitor
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.